Tyvaso 64 MCG kit
Ended Awarded
- Contract number
- 36C24526N0263
- Awardee
-
United Therapeutics Corp UEI KK5FBFA43JS7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $17,352
Award facts
- Contract value 100% obligated
- $17,351.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
United Therapeutics Corp, a biotechnology manufacturer specializing in treatments for pulmonary arterial hypertension and cancer, was awarded a delivery order valued at $17,351.60 by Veterans Integrated Service Network 5 (VISN 5) for Tyvaso 64 microgram inhalation kits. The award, issued on January 22, 2026, with a completion date of January 28, 2026, operates under a firm fixed-price delivery order structure with no set-aside designation applied. The pharmaceutical products will be delivered to a facility in Bartlett, Tennessee, and the award falls under the General Services Administration's Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), reflecting United Therapeutics' status as a pre-competed GSA Schedule contractor.
This delivery order is executed under United Therapeutics' broader single-award Blanket Purchase Agreement with the Department of Veterans Affairs National Acquisition Center, valued at $207.1 million with a ceiling date of April 23, 2026. The BPA encompasses four critical pharmaceutical products—Unituxin, Remodulin, Tyvaso, and Orenitram—enabling Veterans Integrated Service Networks nationwide to procure specialized medications at pre-negotiated prices without competition. This structure allows the Veterans Health Administration to efficiently manage supply chains while ensuring reliable access to these essential therapeutic products across its integrated healthcare network serving the veteran population.
Quick answers
Who was awarded contract 36C24526N0263?
36C24526N0263 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 22, 2026.
How much is contract 36C24526N0263 worth?
The government has obligated $17,352 on 36C24526N0263.
Is contract 36C24526N0263 an order under another contract?
Yes. 36C24526N0263 is a delivery order under 36F79720D0104, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0263 competed?
The extent of competition for 36C24526N0263 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award